MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites.
Prof Peter JepsenHugh WatsonStewart MacdonaldHendrik VilstrupRajiv JalanPublished in: Alimentary pharmacology & therapeutics (2020)
We did not succeed in developing a prediction model that was superior to the MELD score among patients with cirrhosis and severe ascites.